I saw this article today and wondered if this drug would help Bill.
"The medicine, brolucizumab, has now been approved by NHS chiefs for patients with wet age-related macular deterioration – a painless yet incurable eye disease that's the leading cause of blindness in over-55s.
Previously, sufferers needed monthly injections, carried out in hospital, to slow the condition's progress. But the new jab needs to be given only every 12 weeks, while some patients may be able to go even longer between appointments.
During a trial, a third of patients given brolucizumab experienced significant vision gains within just four weeks of their initial jab, compared with six months when given the older drugs.
In trials, the vision of two-thirds of patients given brolucizumab improved by several lines on the eye chart over six months, and the effect is expected to last about two years.
Eye surgeon Professor Faruque Ghanchi at Bradford Teaching Hospitals NHS Foundation Trust, who was involved in trials of brolucizumab, said: 'Anti-VEGFs have been a game-changer for wet AMD, in terms of preventing blindness. 'With brolucizumab, patients will need a starter dose of three injections over three months before moving on to a once-every-three-months schedule."